FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution
Executive Summary
House Energy and Commerce Committee refines FDA Reauthorization Act and adopts a ‘sense of Congress’ resolution on drug pricing, but largely steers clear of other potentially controversial add-ons that could bog down the measure.
You may also be interested in...
Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes
BIO cautioned that its members may have difficulties meeting the purchase orders of product for generic sponsors, while PhRMA contended legislation is not necessary.
Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes
BIO cautioned that its members may have difficulties meeting the purchase orders of product for generic sponsors, while PhRMA contended legislation is not necessary.
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
House passes bill reauthorizing FDA user fee programs via voice vote and makes many other policy changes, but in the process touts the bill's potential to push drug prices lower.